Vísi Probíta for Pain Relief
I recently learned about this 100% bio available collagen from a friend that is to provide cushioning for my aching knees but other benefits to the skin, hair and nails are miraculous. Bill and I have been taking Probita for 2 weeks so I will report back to you our results. We did play 11 hours of tennis at camp this weekend and I didn’t think I would be able to keep up. Bill and I not only did it but we had no aches and pains afterward so I wanted to share this with my friends who like to keep up with the miracles of supplements or who have health challenges. Blessings! -Floranne Probita for pain relief
I am a sixty-seven year old New Mexico rancher and housewife. I have tried many “miracle products” because I have Rheumatoid arthritis and Osteoarthritis. Perhaps because I refuse to sit around and do nothing in order to “protect” my joints, my pain levels often reach, on a scale of 1 to 10, and 8 or higher. I signed up as a Preferred Customer and began to eat the delicious candy. I soon went from that 8 on the scale to a 1 or 2, heading for zero! Along the way I got stronger nails, healthier, thicker hair, nicer skin, and better, sounder, more restful sleep. I am so amazed! There are no side-effects….it actually is nutrition… and plenty of wonderful side-benefits! I can’t recommend this product highly enough! -Betty M.
Probita Testimony… Today is my 4th day of consistently taking my Probita 2X/day. I have had chronic knee pain & shoulder pain, that I felt especially in the morning. Today I was up walking around & noticed that I did not have my usual pain & catching feeling in my knee & also my shoulder did not hurt either. In fact, I still do not have any pain as my day has progressed. This is AMAZING to me!!! –Colleen in Wisconsin Probita for pain relief
Here are a few published medical studies:
24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain.
BACKGROUND: Collagen hydrolysate is a nutritional supplement that has been shown to exert an anabolic effect on cartilage tissue. Its administration appears beneficial in patients with osteoarthritis.
OBJECTIVE: To investigate the effect of collagen hydrolysate on activity-related joint pain in athletes who are physically active and have no evidence of joint disease
CONCLUSION: This was the first clinical trial of 24-weeks duration to show improvement of joint pain in athletes who were treated with the dietary supplement collagen hydrolysate. The results of this study have implications for the use of collagen hydrolysate to support joint health and possibly reduce the risk of joint deterioration in a high-risk group. Despite the study’s size and limitations, the results suggest that athletes consuming collagen hydrolysate can reduce parameters (such as pain) that have a negative impact on athletic performance. Future studies are needed to support these findings.
Role of collagen hydrolysate in bone and joint disease.
OBJECTIVES: To review the current status of collagen hydrolysate in the treatment of osteoarthritis and osteoporosis.
CONCLUSIONS: Collagen hydrolysate is of interest as a therapeutic agent of potential utility in the treatment of osteoarthritis and osteoporosis. Its high level of safety makes it attractive as an agent for long-term use in these chronic disorders.
Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration.
A pilot study was conducted for 42 days to evaluate the efficacy of UC-II (10 mg/day) in five female subjects (58-78 years) suffering from significant joint pain. Significant pain reduction including morning stiffness, stiffness following periods of rest, pain that worsens with use of the affected joint and loss of joint range of motion and function was observed. Thus, UC-II may serve as a novel therapeutic tool in joint inflammatory conditions and symptoms of OA and RA
Arginine L-alpha-ketoglutarate, methylsulfonylmethane, hydrolyzed type I collagen and bromelain in rotator cuff tear repair: a prospective randomized study.
CONCLUSION: The use of the supplement for 3 months after cuff repair decreases shoulder post-operative pain and leads to a slight improvement in repair integrity.
What are your OTC Pain meds doing to you?
FDA reevaluating safety of pain medications following multiple studies showing major harm
NSAIDs can cause major heart damage after just a few days of use, says study
Though the FDA is not required to form policy based on the recommendations of its advisory panels, the agency almost always does, which has left naproxen supporters like Professor Michael Farkouh from the Icahn School of Medicine at Mount Sinai reeling. He recently expressed to USA Today his belief that the FDA could somehow “save lives” if it recommended naproxen over other common pain medications.
But not everyone agrees with this assessment, including Elliott Antman, president-elect of the American Heart Association (AHA). He explained to reporters that a scientific consensus cannot be reached based on the available science, which fails to show any significant safety risk variance among currently approved NSAIDs.
“While there is a scientific rationale to believe that naproxen is safer than the other commonly used NSAIDs, the available data from clinical trials and observational studies is not compelling enough to make a definitive statement,” Antman is quoted as saying. “The vote by the Advisory Committee reflects that uncertainty.”
New research out of Denmark further muddies the waters, revealing that the short-term heart risks associated with NSAIDs are far more serious than health authorities have led us all to believe. Based on their assessment, which the FDA advisory panel considered prior to voting against naproxen’s reclassification, heart problems caused by the use of NSAIDs can manifest in a matter of just a few days.
“I think advice to clinicians needs to be that these events can occur from the start of therapy,” stated panel member Linda Tyler, a professor of pharmacy practice at the University of Utah College of Pharmacy, as quoted by USA Today.